According to research published in Jama Network Open, significant incidental findings on low-dose CT (LDCT) lung scans may indicate other types of cancers. The researchers at the Brown University School of Public Health have analysed data from the National Lung Screening Trial and found that certain abnormalities found in lung CT scans during lung cancer screenings could be signs of other undiagnosed cancers, particularly in the urinary system, lymphoma and leukemia.
Rise in Incidental Findings During Screenings
Doctors are seeing an increasing number of incidental findings unrelated to the lungs during the lung cancer screenings. This study helps to establish an evidence-based approach for evaluating these unexpected abnormalities. The researchers at the Brown University have analysed data from over 26000 participants in the National Lung Screening Trial. They found that about 3% of screening rounds and 6.8% of participants had abnormalities that were identified as potentially indicative of cancer outside the lungs.
Understanding the Role of LDCT Scans
LDCT for lung cancer screening often detects incidental findings that are unrelated to lung cancer but they may have clinical significance. The research team noted a lack of data on whether these incidental findings are associated with extrapulmonary cancer diagnoses.
Key Findings from the Study
In this study, the researchers have reviewed data from 26,445 participants from the National Lung Screening Trial who had up to three rounds of LDCT screenings. All of these patients had at least a 30 pack/year smoking history. The researchers found that patients who had one or more detected cancer SIFs in LDCT screening had a marginal risk difference of 13.89 per 1000 participants in comparison to those with no cancer SIFs for developing extrapulmonary cancer within a year.
Study Limitations
The limitations of the study included the small number of SIFs in each category and lack of clarity whether early detection of extrapulmonary cancers is related to reduced cancer-specific mortality.
The information shared in this blog is for educational purposes only. You should always consult with your healthcare professional for any medical needs.
Subscribe to our newsletter or follow us on Facebook or X today to stay informed and never miss an update!